|
|
Jim Byard's Health Beat |
|
7/22/2010
The FDA has stopped GlaxoSmithKline from adding new patients to clinical trials of the diabetes drug Avandia. The agency is probing whether the medication has heart risks that would warrant removing it from pharmacy shelves in the U.S. Patients who are currently involved in the clinical trial call Tide can remain in the program. An FDA advisory panel voted last week to allow sales of the drug to continue.
|
«
Return to previous page
»
Send to a friend
|
|
|
On Air Now
 |
|
5:30AM - 10AM
|
Weather
|